Filtered By:
Source: Cardiology Journal
Condition: Bleeding
This page shows you your search results in order of relevance. This is page number 4.
Order by Relevance | Date
Total 102 results found since Jan 2013.
P2Y12 inhibitor monotherapy in complex percutaneous coronary intervention: A post-hoc analysis of SMART-CHOICE randomized clinical trial
CONCLUSIONS: P2Y₁₂ inhibitor monotherapy, mostly clopidogrel, following 3 months of DAPT did not increase ischemic events in patients with complex PCIs.PMID:34523115 | DOI:10.5603/CJ.a2021.0101
Source: Cardiology Journal - September 15, 2021 Category: Cardiology Authors: Ji Woong Roh Joo-Yong Hahn Ju-Hyeon Oh Woo Jung Chun Yong Hwan Park Woo Jin Jang Eul-Soon Im Jin-Ok Jeong Byung Ryul Cho Seok Kyu Oh Kyeong Ho Yun Deok-Kyu Cho Jong-Young Lee Young-Youp Koh Jang-Whan Bae Jae Woong Choi Wang Soo Lee Hyuck Jun Yoon Seung Uk Source Type: research
The efficacy and safety of quantitative flow ratio-guided complete revascularization in patients with ST-segment elevation myocardial infarction and multivessel disease: A pilot randomized controlled trial
CONCLUSIONS: In conclusion, STEMI and MVD patients can benefit from QFR-G-CR of non-IRA lesions in the initial stages of acute MI. This can help reduce incidences of major adverse cardiovascular events and unstable angina, relative to IRA treatment only. Chinese Clinical Trial Registration number: ChiCTR2100044120.PMID:34581424 | DOI:10.5603/CJ.a2021.0111
Source: Cardiology Journal - September 28, 2021 Category: Cardiology Authors: Jing Zhang Mingyan Yao Xinwei Jia Huiping Feng Jingjing Fu Wei Tang Hongliang Cong Source Type: research
P2Y12 inhibitor monotherapy in complex percutaneous coronary intervention: A post-hoc analysis of SMART-CHOICE randomized clinical trial
CONCLUSIONS: P2Y₁₂ inhibitor monotherapy, mostly clopidogrel, following 3 months of DAPT did not increase ischemic events in patients with complex PCIs.PMID:34523115 | DOI:10.5603/CJ.a2021.0101
Source: Cardiology Journal - September 15, 2021 Category: Cardiology Authors: Ji Woong Roh Joo-Yong Hahn Ju-Hyeon Oh Woo Jung Chun Yong Hwan Park Woo Jin Jang Eul-Soon Im Jin-Ok Jeong Byung Ryul Cho Seok Kyu Oh Kyeong Ho Yun Deok-Kyu Cho Jong-Young Lee Young-Youp Koh Jang-Whan Bae Jae Woong Choi Wang Soo Lee Hyuck Jun Yoon Seung Uk Source Type: research
The efficacy and safety of quantitative flow ratio-guided complete revascularization in patients with ST-segment elevation myocardial infarction and multivessel disease: A pilot randomized controlled trial
CONCLUSIONS: In conclusion, STEMI and MVD patients can benefit from QFR-G-CR of non-IRA lesions in the initial stages of acute MI. This can help reduce incidences of major adverse cardiovascular events and unstable angina, relative to IRA treatment only. Chinese Clinical Trial Registration number: ChiCTR2100044120.PMID:34581424 | DOI:10.5603/CJ.a2021.0111
Source: Cardiology Journal - September 28, 2021 Category: Cardiology Authors: Jing Zhang Mingyan Yao Xinwei Jia Huiping Feng Jingjing Fu Wei Tang Hongliang Cong Source Type: research
Transcatheter aortic valve implantation results are not superimposable to surgery in patients with aortic stenosis at low surgical risk
CONCLUSIONS: TAVI and SVAR in the treatment of AS in the patients at low surgical risk are not superimposable. In particular, if 30-day and 1-year mortality, major bleeding and acute kidney injury were significantly lower for TAVI, the need of new PM implantation and paravalvular leak were significantly lower in SAVR. Consequently, we suggest the need of more trials to evaluate the effectiveness of TAVI as routine therapeutic procedure in the treatment of patients with low surgical risk AS.PMID:34622437 | DOI:10.5603/CJ.a2021.0114
Source: Cardiology Journal - October 8, 2021 Category: Cardiology Authors: Maria Cristina Acconcia Marco Alfonso Perrone Domenico Sergi Marco Di Luozzo Massimo Marchei Pasquale De Vico Antonio Sili Scavalli Giuseppe Pannarale Marcello Chiocchi Carlo Gaudio Francesco Romeo Quintilio Caretta Francesco Barill à Source Type: research
The efficacy and safety of quantitative flow ratio-guided complete revascularization in patients with ST-segment elevation myocardial infarction and multivessel disease: A pilot randomized controlled trial
CONCLUSIONS: In conclusion, STEMI and MVD patients can benefit from QFR-G-CR of non-IRA lesions in the initial stages of acute MI. This can help reduce incidences of major adverse cardiovascular events and unstable angina, relative to IRA treatment only. Chinese Clinical Trial Registration number: ChiCTR2100044120.PMID:34581424 | DOI:10.5603/CJ.a2021.0111
Source: Cardiology Journal - September 28, 2021 Category: Cardiology Authors: Jing Zhang Mingyan Yao Xinwei Jia Huiping Feng Jingjing Fu Wei Tang Hongliang Cong Source Type: research
Transcatheter aortic valve implantation results are not superimposable to surgery in patients with aortic stenosis at low surgical risk
CONCLUSIONS: TAVI and SVAR in the treatment of AS in the patients at low surgical risk are not superimposable. In particular, if 30-day and 1-year mortality, major bleeding and acute kidney injury were significantly lower for TAVI, the need of new PM implantation and paravalvular leak were significantly lower in SAVR. Consequently, we suggest the need of more trials to evaluate the effectiveness of TAVI as routine therapeutic procedure in the treatment of patients with low surgical risk AS.PMID:34622437 | DOI:10.5603/CJ.a2021.0114
Source: Cardiology Journal - October 8, 2021 Category: Cardiology Authors: Maria Cristina Acconcia Marco Alfonso Perrone Domenico Sergi Marco Di Luozzo Massimo Marchei Pasquale De Vico Antonio Sili Scavalli Giuseppe Pannarale Marcello Chiocchi Carlo Gaudio Francesco Romeo Quintilio Caretta Francesco Barill à Source Type: research
